Literature DB >> 21355837

Role of polyunsaturated fatty acids and fatty acid binding protein in the pathogenesis of schizophrenia.

Motoko Maekawa1, Yuji Owada, Takeo Yoshikawa.   

Abstract

Schizophrenia is a debilitating mental disorder that afflicts about 1% of the population worldwide. Despite intensive, multifaceted research, its exact etiology remains elusive. Epidemiological data shows that when pregnant mothers experienced malnutrition or famine (e.g. the Dutch Hunger Winter of 1994-1945 and the Chinese famine of 1959-1961), the risk of schizophrenia in their children increased by two fold. This fact could be considered in the context of Developmental Origins of Health and Disease (DOHaD) or fetal programming. The concept of DOHaD is well referenced in the understanding of adult metabolic diseases, but less so in the field of mental disorders. We will attempt to show how the mechanisms of DOHaD could contribute at least in part to schizophrenia pathogenesis. Resonating with this concept, we introduce mainly our data showing increased expression of genes for fatty acid binding proteins (FABPs) in the postmortem brains from patients with schizophrenia and the beneficial effect conferred by the administration of polyunsaturated fatty acids (PUFAs) during the early developmental period of rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355837     DOI: 10.2174/138161211795049615

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

Review 1.  Blastocyst-Derived Stem Cell Populations under Stress: Impact of Nutrition and Metabolism on Stem Cell Potency Loss and Miscarriage.

Authors:  Yu Yang; Alan Bolnick; Alexandra Shamir; Mohammed Abdulhasan; Quanwen Li; G C Parker; Elizabeth E Puscheck; D A Rappolee
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

2.  A structure-function mechanism for schizophrenia.

Authors:  Kunjumon I Vadakkan
Journal:  Front Psychiatry       Date:  2012-12-28       Impact factor: 4.157

3.  FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation.

Authors:  Kazem Sharifi; Yusuke Morihiro; Motoko Maekawa; Yuki Yasumoto; Hisae Hoshi; Yasuhiro Adachi; Tomoo Sawada; Nobuko Tokuda; Hisatake Kondo; Takeo Yoshikawa; Michiyasu Suzuki; Yuji Owada
Journal:  Histochem Cell Biol       Date:  2011-09-22       Impact factor: 4.304

4.  Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies.

Authors:  Chie Shimamoto; Tetsuo Ohnishi; Motoko Maekawa; Akiko Watanabe; Hisako Ohba; Ryoichi Arai; Yoshimi Iwayama; Yasuko Hisano; Tomoko Toyota; Manabu Toyoshima; Katsuaki Suzuki; Yukihiko Shirayama; Kazuhiko Nakamura; Norio Mori; Yuji Owada; Tetsuyuki Kobayashi; Takeo Yoshikawa
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

5.  Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes.

Authors:  M Maekawa; A Watanabe; Y Iwayama; T Kimura; K Hamazaki; S Balan; H Ohba; Y Hisano; Y Nozaki; T Ohnishi; M Toyoshima; C Shimamoto; K Iwamoto; M Bundo; N Osumi; E Takahashi; A Takashima; T Yoshikawa
Journal:  Transl Psychiatry       Date:  2017-09-05       Impact factor: 6.222

6.  Nuclear FABP7 regulates cell proliferation of wild-type IDH1 glioma through caveolae formation.

Authors:  Yoshiteru Kagawa; Banlanjo Abdulaziz Umaru; Masayuki Kanamori; Ryo Zama; Subrata Kumar Shil; Hirofumi Miyazaki; Shuhei Kobayashi; Tunyanat Wannakul; Shuhan Yang; Teiji Tominaga; Yuji Owada
Journal:  Mol Oncol       Date:  2021-11-09       Impact factor: 6.603

7.  Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients.

Authors:  Takeshi Fukushima; Hideaki Iizuka; Ayaka Yokota; Takehiro Suzuki; Chihiro Ohno; Yumiko Kono; Minami Nishikiori; Ayaka Seki; Hideaki Ichiba; Yoshinori Watanabe; Seiji Hongo; Mamoru Utsunomiya; Masaki Nakatani; Kiyomi Sadamoto; Takashi Yoshio
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.